A Single-dose Study to Investigate the Effects of 4 Different Doses of Inhaled AZD8683 in Chronic Obstructive Pulmonary Disease (COPD) Patients

PHASE2TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions

Chronic Obstructive Pulmonary DiseaseCOPD

Interventions

DRUG

AZD8683

AZD8683 administered via inhalation

DRUG

Placebo

Placebo administered via inhalation

DRUG

Tiotropium

Tiotropium administered via inhalation

Trial Locations (6)

Bialystok

Lodz

Proszowice

Wroclaw

Gothenburg

Lund